Cargando…

Sonographic Evaluation of the Pancreas in Type 1 Diabetes Mellitus: A Case-control Study

BACKGROUND: Pancreas is a vital insulin-producing gland, and it is subjected to various disorders which produce alteration in the morphology and function. Ultrasound (US) of the pancreas is sensitive for evaluating the gland and provides the accurate diagnosis of pancreatic diseases. The aim of this...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdulrahman, Safa, Ibrahim, Ahmed Abdelrahim, Mohamed, Mohamed Adam, Gameraddin, Moawia, Alelyani, Magbool
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8515619/
https://www.ncbi.nlm.nih.gov/pubmed/34729324
http://dx.doi.org/10.4103/JMU.JMU_89_20
Descripción
Sumario:BACKGROUND: Pancreas is a vital insulin-producing gland, and it is subjected to various disorders which produce alteration in the morphology and function. Ultrasound (US) of the pancreas is sensitive for evaluating the gland and provides the accurate diagnosis of pancreatic diseases. The aim of this study is to determine whether there were alterations in pancreatic size and echogenicity in type 1 diabetes mellitus (DM). METHODS: A total of 100 patients with Type-1 DM (insulin dependent) were examined using the ultrasonography. They were compared to 22 healthy controls. Measurements of the pancreas were performed on type 1 diabetic patients and controls. RESULTS: Pancreatic diameters of the head, body, and tail of the pancreas were reduced in Type 1 DM versus controls (1.78 vs. 1.80 cm, 95% confidence interval [CI]: −0.147 −0.099, P = 0.699 for the head of the pancreas; and 1.093 vs. 1.13 cm: 95% CI: −2.97–1.196, P = 0.484 for the body of the pancreas; 1.12 vs. 1.46 cm, 95% CI: −0.491–0.194, P < 0.001 for the tail of the pancreas). The echogenicity of the pancreas in patients with Type 1 DM increased significantly as the duration of the disease increased (P = 0.015). CONCLUSION: Individuals with Type 1 DM have reduced pancreatic size in comparison with controls. Patients with Type 1 DM have increased echogenicity of the pancreas as the duration of the disease increased.